Cargando…

Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study

INTRODUCTION: Anticholinergic burden may be an important risk factor for the cognitive impairment. Especially in polypharmacy, even drugs with low anticholinergic effects may contribute to a significant anticholinergic burden. The drugs with anticholinergic effects are used in treatment of motor and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumbul-Sekerci, Betul, Bilgic, Basar, Pasin, Ozge, Emre, Murat, Hanagasi, Hasmet A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909708/ https://www.ncbi.nlm.nih.gov/pubmed/36273437 http://dx.doi.org/10.1159/000526863

Ejemplares similares

Neuroimaging, Biomarkers, and Management of Dementia with Lewy Bodies
por: Hanagasi, Hasmet A., et al.
Publicado: (2013)

Cognition and BDNF levels in prediabetes and diabetes: A mediation analysis of a cross-sectional study
por: Sumbul-Sekerci, Betul, et al.
Publicado: (2023)

The evaluation of relationship between polypharmacy and anticholinergic burden scales
por: Okudur, Saadet Koc, et al.
Publicado: (2021)

A novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family()
por: Guerreiro, Rita, et al.
Publicado: (2013)

Polypharmacy and cumulative anticholinergic burden in older adults hospitalized with fall
por: Wong, Ho Lun, et al.
Publicado: (2023)

Anticholinergic drugs and incident dementia, mild cognitive impairment and cognitive decline: a meta-analysis
por: Pieper, Nina T, et al.
Publicado: (2020)

The Impact of Anticholinergic Use for Overactive Bladder on Cognitive Changes in Adults with Normal Cognition, Mild Cognitive Impairment, or Dementia
por: Welk, Blayne, et al.
Publicado: (2022)

Multicenter study of levodopa carbidopa intestinal gel in Parkinson’s disease: the Turkish experience
por: GÜLTEKİN, Murat, et al.
Publicado: (2020)

Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment
por: Meng, Dewen, et al.
Publicado: (2022)

Genotype–Phenotype correlations of SCARB2 associated clinical presentation: a case report and in-depth literature review
por: Atasu, Burcu, et al.
Publicado: (2022)

Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson’s disease patients
por: Karaaslan, Zerrin, et al.
Publicado: (2021)

Dopamine Agonist-Associated Hiccup in Parkinson’s Disease: A Case Report
por: EMEKLİ, Ahmed Serkan, et al.
Publicado: (2019)

PLA2G6 Mutations Related to Distinct Phenotypes: A New Case with Early-onset Parkinsonism
por: Giri, Anamika, et al.
Publicado: (2016)

The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia
por: Ang, Mei San, et al.
Publicado: (2017)

The Predictive Value of Anticholinergic Burden Measures in Relation to Cognitive Impairment in Older Chronic Complex Patients
por: Tristancho-Pérez, Ángela, et al.
Publicado: (2022)

Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study
por: Krüger, Caroline, et al.
Publicado: (2021)

Caregiver burden is increased in Parkinson’s disease with mild cognitive impairment (PD-MCI)
por: Jones, Ann J., et al.
Publicado: (2017)

ANTICHOLINERGIC DRUGS: CUT-OFF FOR IMPAIRED COGNITION AND MOBILITY IN SENIORS
por: ATTOH-MENSAH, Elpidio K, et al.
Publicado: (2019)

Characterization of cognition in mild cognitive impairment with and without Parkinson's disease
por: Auclair-Ouellet, N., et al.
Publicado: (2020)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

Mild Cognitive Impairment in Parkinson’s Disease—What Is It?
por: Weil, Rimona S., et al.
Publicado: (2018)

Donepezil for mild cognitive impairment in Parkinson’s disease
por: Baik, Kyoungwon, et al.
Publicado: (2021)

Polypharmacy Cut-Off for Gait and Cognitive Impairments
por: Langeard, Antoine, et al.
Publicado: (2016)

Anticholinergic Burden and Cognitive Performance in Patients With Schizophrenia: A Systematic Literature Review
por: Georgiou, Rafaella, et al.
Publicado: (2021)

PS95. Cognitive impairment of remitted depression in medication with anticholinergic activity
por: Maeshima, Hitoshi, et al.
Publicado: (2016)

Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients
por: Guven, Gamze, et al.
Publicado: (2016)

Delirium is not associated with anticholinergic burden or polypharmacy in older patients on admission to an acute hospital: an observational case control study
por: Moorey, Hannah C., et al.
Publicado: (2016)

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models
por: Al Rihani, Sweilem B., et al.
Publicado: (2021)

Improving quantification of anticholinergic burden using the Anticholinergic Effect on Cognition Scale – a healthcare improvement study in a geriatric ward setting
por: Balasundaram, Bharathi, et al.
Publicado: (2022)

Mild cognitive impairment in Parkinson’s disease: the challenge and the promise
por: Fernandez, Hubert H, et al.
Publicado: (2005)

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
por: Lawrence, Blake J., et al.
Publicado: (2016)

Precuneus Dysfunction in Parkinson’s Disease With Mild Cognitive Impairment
por: Jia, Xiuqin, et al.
Publicado: (2019)

metabolic profiling of Parkinson's disease and mild cognitive impairment
por: Burté, Florence, et al.
Publicado: (2017)

Imaging Mild Cognitive Impairment and Dementia in Parkinson's Disease
por: Sasikumar, Sanskriti, et al.
Publicado: (2020)

Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients
por: Pfistermeister, Barbara, et al.
Publicado: (2017)

Anticholinergic Cognitive Burden as a Predictive Factor for In-hospital Mortality in Older Patients in Korea
por: Lee, Jae Hyun, et al.
Publicado: (2020)

Anticholinergic burden in middle and older age is associated with reduced cognitive function, but not with brain volume.
por: Mur, Jure, et al.
Publicado: (2022)

Roles of Education and IQ in Cognitive Reserve in Parkinson's Disease-Mild Cognitive Impairment
por: Armstrong, M.J., et al.
Publicado: (2012)

Cognitive Profiles of Patients with Mild Cognitive Impairment or Dementia in Alzheimer's or Parkinson's Disease
por: Hildebrandt, Helmut, et al.
Publicado: (2013)

CSF neurochemical profile and cognitive changes in Parkinson’s disease with mild cognitive impairment
por: Paolini Paoletti, Federico, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vcl6tnsuv93c6agh0d96dlqe2g